zealand pharma a/s
(ZEAL:Copenhagen Stock Exchange)
Earnings & Estimates Summary - ZEALAND PHARMA A/S (ZEAL)
2013 revenues at Zealand Pharma A/S totaled kr6.6M DKK, while annual losses equaled kr8.10 per share.
Quarterly Earnings & Estimates - ZEALAND PHARMA A/S (ZEAL)
Zealand Pharma A/S's Quarterly Earnings
Zealand Pharma A/S reported 2nd quarter 2014 losses of kr2.10 per share on 08/23/2014.
Annual Earnings & Estimates - ZEALAND PHARMA A/S (ZEAL)
Zealand Pharma A/S's Annual Earnings
Zealand Pharma A/S reported annual 2013 losses of kr8.10 per share on 03/22/2014.
Quarterly Revenues - ZEALAND PHARMA A/S (ZEAL)
Zealand Pharma A/S's Quarterly Revenues
Zealand Pharma A/S had 2nd quarter 2014 revenues of kr4.3M DKK. This missed the kr7.8M DKK estimate of the one analyst following the company. This was 297.6% above the prior year's 2nd quarter results.
Annual Revenues - ZEALAND PHARMA A/S (ZEAL)
Zealand Pharma A/S's Annual Revenues
Zealand Pharma A/S had revenues for the full year 2013 of kr6.6M DKK. This was -97.1% below the prior year's results.
|No competitor information is available for ZEAL.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|